EPRSQ — Epirus Biopharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Jennison Associates dissolves passive stake in Epirus Biopharmaceuticals
Brief: Epirus Biopharmaceuticals enters term sheet with Zaklady Farmaceutyczne
Brief: Epirus Biopharmaceuticals announces reprioritization of pipeline
Brief: Epirus biopharmaceuticals files for non-timely 10-k - sec filing
Brief: Epirus Biopharmaceuticals Q4 loss per share $0.63
Brief: Epirus Biopharmaceuticals files for issuance and sale of up to $30 mln of co's shares
Brief: Epirus Biopharmaceuticals - entered into at-the-market sales agreement pursuant to which company may sell up to $30 mln in shares
Brief: Epirus Biopharmaceuticals initiates phase 3 clinical study
Brief: Epirus Biopharmaceuticals gives update on bow015 (infliximab biosimilar)
Brief: Epirus Biopharmaceuticals Q3 revenue $0.2 mln
Brief: Epirus Biopharmaceuticals reschedules Q3 2015 financial results conference call
Brief: Epirus Biopharmaceuticals entered into share purchase agreement with Taro Pharmaceuticals
Brief: Livzon Pharma plans industry fund, unit in alliance with Epirus Switzerland
Brief: Epirus Biopharmaceuticals acquires Bioceros
Brief: Epirus Biopharmaceuticals reports Q2 loss of $0.65 per share
Brief: Epirus Biopharma, Polpharma enter profit-sharing collaboration
Brief: Epirus Biopharmaceuticals amends its certificate of incorporation
Brief: Epirus Biopharmaceuticals reports Q1 loss per share $0.39
Brief: Epirus says Epirus Switzerland gmbh signed settlement agreement with Reliance Life Sciences